Molecure SA (1B1) Stock Price & News

All values in PLN	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	214.80K	2.95M	932.24K	932.24K
Cost of goods sold	362.37K	21.71M	120.45K	120.45K
Cost of revenue	362.37K	21.71M	120.45K	120.45K
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	4.48M	-14.43M	3.15M	3.15M
Operating expense	5.30M	-16.96M	3.98M	3.98M
Total operating expenses	5.66M	4.75M	4.10M	4.10M
Operating income	-5.45M	-1.81M	-3.17M	-3.17M
Other non operating income	-	801.03K	60.89K	60.89K
EBT including unusual items	-5.27M	-1.73M	-3.15M	-3.15M
EBT excluding unusual items	-5.27M	-1.73M	-3.15M	-3.15M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	75.87K	-191.15K	227.93K	227.93K
Net income	-5.27M	-1.73M	-3.15M	-3.15M
Net profit margin	-2,451.83%	-58.66%	-338.28%	-338.28%
Earnings per share	-	-	-	-
Interest and investment income	212.00K	40.09K	-	-
Interest expense	-30.99K	-811.85K	-44.31K	-44.31K
Net interest expenses	181.01K	-771.76K	-44.31K	-44.31K
Depreciation and amortization charges	745.28K	-2.33M	607.71K	607.71K
EBITDA	-5.22M	-1.58M	-2.56M	-2.56M
Gain or loss from assets sale	-39.50K	58.44K	-94.69K	-94.69K

Finance